Carsten Thilo Herz

Carsten Thilo Herz

Auto-generated profile, based on publicly available information

Carsten Thilo Herz

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
CHCarsten T. Herz
Carsten T. Herz
FKFlorian W. Kiefer
Florian W. Kiefer
In the midst of an obesity epidemic, the promotion of brown adipose tissue (BAT) function and the browning of white adipose tissue (WAT) have emerged as promising therapeutic targets to increase energy expenditure and counteract weight gain. Despite the fact that the thermogenic potential of bone fide BAT in rodents is several orders of magnitudes higher than white fat containing brite/beige adipocytes, WAT browning represents a particularly intriguing concept in humans given the extreme amount of excess WAT in obese individuals. In addition, the clear distinction between classic brown and beige fat that has been proposed in mice does not exist in humans. In fact, studies of human BAT biopsies found controversial results suggesting both classic brown and beige characteristics. Irrespective of the true ‘color’, accumulating evidence suggests the induction of thermogenic adipocytes in human WAT depots in response to specific stimuli, highlighting that WAT browning may occur in both, mice and humans. These observations also emphasize the great plasticity of human fat depots and raise important questions about the metabolic properties of thermogenically active adipose tissue in humans and the potential therapeutic implications. We will first review the cellular and molecular aspects of selected adipose tissue browning concepts that have been identified in mouse models with emphasis on neuronal factors, the microbiome, immune cells and several hormones. We will also summarize the evidence for adipose tissue browning in humans including some experimental pharmacologic approaches.

28 August 2017 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
EKEva-Christina Krzizek
Eva-Christina Krzizek
JBJohanna Maria Brix
Johanna Maria Brix
CHCarsten Thilo Herz
Carsten Thilo Herz
HKHans Peter Kopp
Hans Peter Kopp
GSGerit-Holger Schernthaner
Gerit-Holger Schernthaner
BLBernhard Ludvik
Bernhard Ludvik

28 April 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
OKOana C Kulterer
Oana C Kulterer
LNLaura Niederstaetter
Laura Niederstaetter
CHCarsten T Herz
Carsten T Herz
AHAlexander R Haug
Alexander R Haug
ABAndrea Bileck
Andrea Bileck
FKFlorian W Kiefer
Florian W Kiefer
Background Accumulating evidence links brown adipose tissue (BAT) to increased cold-induced energy expenditure (CIEE) and regulation of lipid metabolism in humans. BAT has also been proposed as a novel source for biologically active lipid mediators including polyunsaturated fatty acids (PUFAs) and oxylipins. However, little is known about cold-mediated differences in energy expenditure and various lipid species between individuals with detectable BAT (BATpos) and those without (BATneg). Methods Here we investigated a unique cohort of matched BATpos and BATneg individuals identified by [18F]-FDG PET/CT. BAT function, CIEE and circulating oxylipins, were analyzed before and after short-term cold exposure using [18F]-FDG PET/CT, indirect calorimetry and high-resolution mass spectrometry, respectively. Results We found that active BAT is the major determinant of cold-induced energy expenditure since only BATpos individuals experienced significantly increased energy expenditure in response to cold. A single bout of moderate cold exposure resulted in the dissipation of additional 20kcal excess energy in BATpos but not in BATneg individuals. The presence of BAT was associated with a unique systemic PUFA and oxylipin profile characterized by increased levels of anti-inflammatory ω3 fatty acids as well as cytochrome P450 products but decreased concentrations of some pro-inflammatory hydroxyeicosatetraenoic acids when compared to BATneg individuals. Notably, cold exposure raised circulating levels of various lipids, including the recently identified BATokines DiHOME and 12-HEPE, only in BATpos subjects. Conclusions In summary, our data emphasize that BAT in humans is a major contributor towards cold-mediated energy dissipation and a critical organ in the regulation of the systemic lipid pool.

1 August 2021 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
CHCarsten T. Herz
Carsten T. Herz
OKOana C. Kulterer
Oana C. Kulterer
MPMarlene Prager
Marlene Prager
RMRodrig Marculescu
Rodrig Marculescu
FLFelix B. Langer
Felix B. Langer
FKFlorian W. Kiefer
Florian W. Kiefer

13 December 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
MDMatthias Diebold
Matthias Diebold
HVHannes Vietzen
Hannes Vietzen
AHAndreas Heinzel
Andreas Heinzel
SHSusanne Haindl
Susanne Haindl
CHCarsten T. Herz
Carsten T. Herz
GBGeorg A. Böhmig
Georg A. Böhmig
Antibody-mediated rejection (ABMR) is a leading cause of graft failure. Emerging evidence suggests a significant contribution of natural killer (NK) cells to microvascular inflammation (MVI). We investigated the influence of genetically determined NK cell functionality on ABMR development and activity. The study included 86 kidney transplant recipients subjected to systematic biopsies triggered by donor-specific antibody detection. We performed killer immunoglobulin-like receptor typing to predict missing self and genotyped polymorphisms determining NK cell functionality (FCGR3AV/F158 [rs396991], KLRC2wt/del, KLRK1HNK/LNK [rs1049174], rs9916629-C/T). Forty-four patients had ABMR with considerable MVI and elevated NK cell transcripts. Missing self was not related to MVI. Only KLRC2wt/wt showed an association (MVI score: 2 [median; interquartile range: 0-3] versus 0 [0-1] in KLRC2wt/del recipients; p=0.001) and remained significant in a proportional odds multivariable model (odds ratio [OR]: 7.84, 95% confidence interval [CI]: 2.37-30.47, p=0.001). A sum score incorporating all polymorphisms and missing self did not outperform a score including only KLRC2 and FCGR3A variants, which were predictive in univariable analysis. NK cell genetics did not affect graft functional decline and survival. In conclusion, a functional KLRC2 polymorphism emerged as an independent determinant of ABMR activity, without a considerable contribution of missing self and other NK cell gene polymorphisms.

12 November 2016 in Annals of Medicine
Verified
Journal Article
Closed access
CHClemens Höbaus
Clemens Höbaus
CHCarsten Thilo Herz
Carsten Thilo Herz
FOFlorian Obendorf
Florian Obendorf
MHMarie-Therese Howanietz
Marie-Therese Howanietz
TWThomas Wrba
Thomas Wrba
GSGerit-Holger Schernthaner
Gerit-Holger Schernthaner
Objectives: Recent advances in catheter-based intervention in patients with symptomatic peripheral arterial disease (PAD) have halved mortality. Mortality of PAD patients still remains high compared to other clinical forms of atherosclerosis. Intensified patient care might increase adherence to medical management and benefit the survival of PAD patients. Methods: Two patient cohorts were compared in a longitudinal prospective follow-up study. 370 PAD patients were included in the intensified center-based vascular medicine group (VMC group) and 332 PAD patients were treated by their usual primary care physician (PCP group). Survival in both groups was compared by Kaplan–Meier and Cox-regression analyses after 5 years. Results: Survival of patients in the VMC group was 90.8% compared to 66% in the PCP group. Thus, survival was improved by 24.9% by center-based care (absolute risk CI: 19–30.7%; 38% relative risk). PCP treatment increased all-cause mortality by a hazard ratio of 3.7 (95% CI: 2.5–5.5; p < .001). Mortality in the VMC group was significantly associated with the non-modifiable risk factors age, C-reactive protein, and nephropathy in multivariable analyses. Conclusion: These data imply that multi-morbid elderly PAD patients still benefit by intensified specialist care compared to the usual primary care setting.